The story has been updated to include comments from Danaher's CEO.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today reported an 11 percent rise in first-quarter sales with its Life Sciences and Diagnostics segment jumping 22 percent.

For the three months ended April 1, the Washington-based conglomerate said that total sales came in at $3.35 billion, compared to $3.01 billion the year before. Wall Street had a consensus estimate of $3.32 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.